Accendra Health receives NYSE notice over sub-$1 average share price, plans to cure

ACCENDRA HEALTH INC/VA/

NYSE notified Accendra on Oct. 6, 2026 that ACH's average closing price was below $1.00 over 30 consecutive trading days.
Accendra has six months from the notice to regain compliance; closing price and 30-day average must be at least $1.00.
Accendra intends to notify NYSE within 10 business days of its plan to cure, including a possible reverse stock split subject to stockholder approval.
A reverse split, if necessary, would be subject to approval no later than the annual meeting anticipated in May 2027.
Accendra says the notice has no immediate delisting impact and does not affect business, operations or SEC reporting obligations.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.